Related Experiment Video

Updated: Jan 20, 2026

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells
09:45

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells

Published on: May 21, 2019

8.9K

MicroRNAs as Therapeutic Targets in Nasopharyngeal Carcinoma

Sumei Wang1,2,3, François-Xavier Claret4,5, Wanyin Wu1,2

  • 1Guangdong Provincial Key Laboratory of Clinical Research on Traditional Chinese Medicine Syndrome, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China.

Frontiers in Oncology
|August 29, 2019
PubMed

Insights

MicroRNAs (miRNAs) are key in nasopharyngeal carcinoma (NPC) development and progression. Targeting these microRNAs offers a promising new strategy to improve treatment outcomes for NPC patients.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Nasopharyngeal carcinoma (NPC) is an epithelial malignancy with high rates of local invasion and metastasis.
  • Current treatments like chemotherapy and radiotherapy improve survival but persistent or recurrent disease remains a challenge.
  • Novel therapeutic targets are crucial for improving outcomes in NPC patients.

Purpose of the Study:

  • To review the role of microRNAs (miRNAs) in nasopharyngeal carcinoma (NPC) initiation, progression, and treatment.
  • To discuss the potential of miRNAs as biomarkers and therapeutic targets for NPC.
  • To highlight miRNA-based strategies for improving NPC treatment response.

Main Methods:

  • Literature review of studies on miRNA dysregulation in NPC.
  • Analysis of miRNA involvement in NPC tumorigenesis, metastasis, and treatment resistance.
  • Examination of miRNA-based therapeutic approaches and their potential clinical applications.

Main Results:

  • MicroRNA expression is significantly dysregulated in NPC, influencing key cancer processes.
  • miRNAs are implicated in NPC tumorigenesis, invasion, metastasis, and resistance to therapy.
  • miRNA-based treatments can target multiple oncogenic pathways simultaneously.

Conclusions:

  • Dysregulated miRNAs are central to NPC development and progression.
  • miRNAs show significant potential as diagnostic biomarkers and therapeutic targets for NPC.
  • miRNA-based therapies, alone or in combination, may enhance treatment efficacy and cure rates for nasopharyngeal carcinoma.
Keywords:
Nasopharyngeal Carcinoma (NPC)applicationbiomarkermicroRNAtherapeutic target

More Related Videos

Author Spotlight: Investigating Liver Cancer Pathogenesis Using Patient-Derived Organoids07:25

Author Spotlight: Investigating Liver Cancer Pathogenesis Using Patient-Derived Organoids

Published on: August 18, 2023

2.5K
Differentiation of a Human Neural Stem Cell Line on Three Dimensional Cultures, Analysis of MicroRNA and Putative Target Genes10:48

Differentiation of a Human Neural Stem Cell Line on Three Dimensional Cultures, Analysis of MicroRNA and Putative Target Genes

Published on: April 12, 2015

10.5K

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.0K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.8K
Suctioning the Nasopharyngeal Airway01:29

Suctioning the Nasopharyngeal Airway

Nasopharyngeal suctioning is a procedure to remove secretions from the upper part of the respiratory tract that the patient cannot clear independently. It helps maintain airway patency and prevents complications such as aspiration pneumonia.
Equipment Required
3.1K
Therapeutic Index01:13

Therapeutic Index

The therapeutic index of a drug is a key parameter in pharmacology that quantifies the relative safety of a drug by calculating the ratio between the dose that causes toxicity in half the population (50%) to the dose that proves to be effective for half the population (50%). It provides a spectrum of doses for a particular drug ranging from effective to potentially toxic. To illustrate, consider an anticoagulant agent like warfarin. It possesses a narrow window within its therapeutic index to...
6.7K
Therapeutic Communication01:30

Therapeutic Communication

Communication is a lifelong learning process. Through therapeutic communication, nurses can collect relevant assessment data, provide education and counseling, and interact during nursing interventions. Sending and receiving messages occur through verbal and nonverbal communication techniques and can happen separately or simultaneously.
Verbal communication depends on language or a prescribed way of using words so that people can share information effectively. The critical aspects of verbal...
7.5K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
998